Log in

Roche enters into partnership with GE Healthcare in diagnostics

The Swiss pharmaceutical group Roche has entered into a long-term partnership with US-based GE Healthcare to jointly develop an integrated digital diagnostic platform for oncology, the two groups announced on Monday.

The partnership will initially focus on products that will accelerate and improve treatment options for cancer and critical care patients, they said in a statement without disclosing the financial details of the deal.

Through this partnership, the two groups intend to combine the expertise of GE Healthcare, a specialist in medical imaging, in in vivo data with Roche's in vitro data in biomarkers, tissue pathologies and sequencing. of the gene.

a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb - drapeauitalie )

  group    administrators A3P
& Project Managers

letter   newsletter A3P